BlueWhale Bio

Philadelphia, PA · Founded 2022 · Privately Held (backing)

Developer of a cell-based therapeutic platform intended to overcome bottlenecks in gene therapy manufacturing. BlueWhale Bio is based in Philadelphia, PA and was founded in 2022. It was valued at $52 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $23 million across 1 recorded round; the latest was a $5 million early-stage round in Oct 2025.

PMV mark · valuation
$52.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$23.0M
Last round
Early Stage VC
Oct 2025

Who backs BlueWhale Bio?

5 investors
InvestorType
Hillhouse Investment GroupOther
Marshall WaceHedge fund
Novalis LifeSciencesAsset manager
Danaher Ventures—
Penn Center for Innovation—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BlueWhale Bio investors

5 investors are on record for BlueWhale Bio, including Hillhouse Investment Group, Marshall Wace, Novalis LifeSciences and Danaher Ventures. The early-stage round in Oct 2025 drew 1 investor.

Free account
More of BlueWhale Bio with a free account
  • ·Watch BlueWhale Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like BlueWhale Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View